Photosensitive materials and imaging processes using such materials.
Abstract
Photosensitive microcapsules are disclosed which include an internal phase containing a photosensitive composition having a spectral sensitivity range within which the composition hardens upon exposure to radiation. The microcapsules have associated therewith a colour former and an absorber compound which reduces the sensitivity of the microcapsules to actinic radiation over a portion of the spectral sensitivity range. The microcapsules are useful in the formation of polychromatic images. The spectral sensitivity may be adjusted such that three sets of microcapsules having distinctly different spectral sensitivities and individually containing colour formers for full colour imaging can be provided on a single surface and discriminately exposed in a manner which corresponds to the red, green and blue components of an original.

Term
Term ended
Projected expiry passed 17 May 2005, 21.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
18 claims: 6 independent, 12 dependent
- 1Photosensitive microcapsules useful in the formation of polychromatic images, characterised in that said microcapsules include an internal phase containing a photosensitive composition having a spectral sensitivity range within which said composition hardens upon exposure to radiation, and in that said microcapsules have associated therewith a colour former and an absorber compound which reduces the sensitivity of said microcapsules to actinic radiation over a portion of said spectral sensitivity range.
- 2Photosensitive microcapsules according to Claim 1, further characterised in that said microcapsules include a discrete capsule wall.
- 5Photosensitive microcapsules according to Claim 4, wherein said absorber compound is further characterised in that said compound does not substantially inhibit or promote free radical initiated polymerization and said compound possesses an extinction coefficient greater than 100/M cm.
- 9Photosensitive microcapsules according to Claim 8, further characterised in that said absorber absorbs ultraviolet radiation.
- 10Photosensitive microcapsules according to Claim 9, further characterised in that said absorber is selected from hydroxybenzophenones, hydroxyphenylbenzotriazoles, and formamidines.
- 12A photosensitive material comprising a support having on the surface thereof a layer of photosensitive microcapsules, characterised in that said photosensitive microcapsules include an internal phase containing a photosensitive composition having a spectral sensitivity range within which said composition hardens upon exposure to radiation, and in that said microcapsules have associated therewith a colour former and an absorber compound which reduces the sensitivity of said microcapsules to actinic radiation over a portion of said spectral sensitivity range.
- 14Photosensitive material comprising a support having on the surface thereof a layer of photosensitive microcapsules, characterised in that said photosensitive microcapsules include a first set of microcapsules associated with a cyan colour former and containing a first photohardenable composition, a second set of microcapsules associated with a magenta colour former and containing a second photohardenable composition, and a third set of microcapsules associated with a yellow colour former and containing a third photohardenable composition, at least one of said first, second and third sets of microcapsules having associated therewith an absorber which reduces the sensitivity of said microcapsules over a portion of the spectral sensitivity range of the encapsulated photohardenable composition such that said first, second and third sets of microcapsules have sufficiently different sensitivity characteristics that said first photohardenable composition can be hardened upon exposure of said first microcapsules to actinic radiation of a first wavelength without substantially hardening the encapsulated second and third photohardenable compositions, said second photohardenable composition can be hardened upon exposure of said second microcapsules to actinic radiation of a second wavelength without substantially hardening said encapsulated first and third photohardenable compositions, and said third photohardenable composition can be hardened upon exposure of said third microcapsules to actinic radiation of a third wavelength without substantially hardening said encapsulated first and second photohardenable compositions.
- 15Photosensitive material according to Claim 14, further characterised in that at least one of said first, second and third sets of microcapsules is sensitive to ultraviolet radiation.
- 16Photosensitive material according to Claim 14, further characterised in that at least one of said first, second and third photohardenable compositions is sensitive to blue light.
- 18A process for forming an image characterised in that it comprises the steps of image-wise exposing a photosensitive material according to any of Claims 12 to 17;subjecting said microcapsules to a force which causes said microcapsules to release said internal phase and thereby activate said colour former(s);and contacting said released colour former(s) with dry developer which reacts with said colour former(s) to form a colour image.
Independent claims14
93 paragraphs, as filed
0001The present invention relates to photosensitive microcapsules, to photosensitive materials utilising such microcapsules and to imaging processes using such materials.
0002The microcapsules are useful for example, in forming polychromatic or full colour images using the imaging processes described in U.S Patents 4399209 and,4440846 to The Mead Corporation.
0003British Patent Specification 2113860 The Mead Corporation describes a photosensitive material useful in full colour imaging comprising a support haying on the surface thereof microcapsules which individually contain cyan, magenta and yellow colour formers and photosensitive compositions having distinctly different sensitivities. A uniform mixture of the microcapsules is distributed over the surface of the support. Images are formed by separating the red, green and blue components of the image to be reproduced and translating these components into different wavelengths of actinic radiation to which the photosensitive compositions are distinctly sensitive. The photosensitive material is image-wise exposed to the translated radiation and thereafter it is subjected to a uniform rupturing force, such as pressure, which causes the microcapsules in the underexposed and unexposed areas to rupture and release the colour formers.' The colour formers then react with a developer material which is contained on the same or a different support and produce a full colour image.
0004The spectral sensitivity of photosensitive microcapsules is principally a function of the photoinitiator used in the encapsulated photosensitive composition. In order to design photosensitive microcapsules useful in full colour imaging having distinctly different spectral sensitivities, photoinitiators must be designed or selected which have mutually exclusive sensitivities in at least three distinct wavelength regions. That is, the photoinitiator used in microcapsules containing a cyan colour former must be substantially more sensitive in a wavelength region in which the photoinitiators used in the microcapsules associated with the magenta and yellow colour formers are substantially less sensitive or insensitive. Likewise, the photoinitiator used in the microcapsules containing the cyan colour former must be substantially less sensitive and ideally insensitive in a wavelength region in which the photoinitiators used in the microcapsules containing the magenta and yellow colour formers are preferentially sensitive. The same consider, ations govern the selection of the initiators associated with the microcapsules containing the yellow and magenta colour formers.
0005As will become apparent from the description which follows, by associating a radiation absorber with the microcapsules, we have been able substantially to simplify the selection and/or design of microcapsules having mutually exclusive sensitivity characteristics.
0006In accordance with a first aspect of the present invention, there are provided photosensitive microcapsules useful in the formation of polychromatic images, characterised in that said microcapsules include an internal phase containing a photosensitive composition having a spectral sensitivity range within which said composition hardens upon exposure to radiation, and in that said microcapsules have associated therewith a colour former and an absorber compound which reduces the sensitivity of said microcapsules to actinic radiation over a portion of said spectral sensitivity range.
0007By co-ordinating the selection of the.photoinitiators used in the photosensitive compositions with the selection of the absorber such that the absorber "shields" the microcapsules from exposures intended for other microcapsules in a polychromatic system, the microcapsules can be tailored to provide a full colour image. For example, an absorber may be selected for use with the cyan forming microcapsules which prevents those microcapsules from being exposed by exposures within the sensitivity range of the magenta forming capsules. In this manner, the spectral sensitivity of the microcapsules can be more narrowly defined, there is greater exposure latitude and there is greater latitude in the selection of the other photoinitiators used in the system.
0008The absorber can be present in the photosensitive composition itself, in the wall of a microcapsule having a discrete wall, in the binder forming the continuous phase of an open phase microcapsule, or in a binder in which microcapsules having discrete walls are dispersed. Preferably, the absorber is present in the photosensitive composition or in the capsule wall.
0009In a second and alternative aspect of the present invention, we provide a photosensitive material comprising a support having on the surface thereof a layer of photosensitive microcapsules, characterised in that said photosensitive microcapsules include an internal phase containing a photosensitive composition having a spectral sensitivity range within which said composition hardens upon exposure to radiation, and in that said microcapsules have associated therewith a colour former and an absorber compound which reduces the sensitivity of said microcapsules to actinic radiation over a portion of said spectral sensitivity range.
0010We provide, in a third alternative aspect of this invention photosensitive material comprising a support having on the surface thereof a layer of photosensitive microcapsules, characterised in that said photosensitive microcapsules include a first set of microcapsules associated with a cyan colour former and containing a first photohardenable composition, a second set of microcapsules associated with a magenta colour former and containing a second photohardenable composition, and a third set of microcapsules associated with a yellow colour former and containing a third photohardenable composition, at least one of said first, second and third sets of microcapsules having associated therewith an absorber which reduces the sensitivity of said microcapsules over a portion of the spectral sensitivity range of the encapsulated photohardenable composition such that said first, second and third sets of microcapsules have sufficiently different sensitivity characteristics that said first photohardenable composition can be hardened upon exposure of said first microcapsules to actinic radiation of a first wavelength without substantially hardening the encapsulated second and third photohardenable compositions, said second photohardenable composition can be hardened upon exposure of said second microcapsules to actinic radiation of a second wavelength without substantially hardening said encapsulated first and third photohardenable compositions, and said third photohardenable composition can be hardened upon exposure of said third microcapsules to actinic radiation of a third wavelength without substantially hardening said encapsulated first and second photohardenable compositions. The invention, in a fourth alternative aspect thereof, provides a process for forming an image characterised in that it comprises the steps of image-wise exposing a photosensitive material as above defined
0011subjecting said microcapsules to a force which causes said microcapsules to release said internal phase and thereby activate said colour former(s); and contacting said released colour former(s) with dry developer which reacts with said colour former(s) to form a colour image.
0012The term "microcapsule" as used herein includes both microcapsules having a discrete capsule wall and so-called open phase microcapsules formed by dispersing a solution of the photosensitive composition and the, colour former in an appropriate binder.
0013The term "spectral sensitivity range" as used herein refers to the spectral regions in which a photosensitive composition or microcapsule responds to radiation.
0014The term "harden" as used herein means to increase the viscosity or hardness of the internal phase and is not limited strictly to solidification.
0015The present invention will be explained in more detail by way of example only by reference to the accompanying drawings wherein: <ul id="ul0001" list-style="none"><li>Fig. 1 is a graph of the spectral sensitivity curves for a set of microcapsules useful in full colour imaging;</li><li>Fig. 2 is a graph of the spectral sensitivity curves of the microcapsules described in Example 4;</li><li>Fig. 3 is a graph of the spectral sensitivity of a microcapsule containing an absorber compound and the same microcapsule without the absorber (Example 2);</li><li>Fig. 4 is a graph similar to Fig. 3 for a microcapsule containing a different photoinitiator (Example 3); and</li><li>Fig. 5 is a graph of the spectral sensitivity curves of the microcapsules prepared in Example 5.</li></ul>
0016The entire disclosure of our aforesaid British Patent Specification 2113860 is incorporated herein by reference.
0017Figure 1 contains the spectral sensitivity curves for a set of three microcapsules (A, B and C) the spectral sensitivities of which are optimally suited for use in full colour imaging. Capsule A is sensitive in a first range, Capsule B is sensitive in a second range, and Capsule C is sensitive in a third range and none of Capsules A, B and,C are substantially sensitive in the ranges in which the other capsules are sensitive.
0018Because there is often significant overlap in the spectral sensitivities of initiators, it is difficult to achieve the relationship shown in Fig. 1.
0019Fig. 2 is a plot of the spectral sensitivity curves for the microcapsules A', B' and C' of Example 4 below. As can be seen from Fig. 2, the spectral. sensitivities of the microcapsules are not perfectly exclusive, but there are distinct wavelength bands in which each group of capsules can be exposed without substantially exposing the others. The spectral sensitivity curve of Capsule B' overlaps with that of Capsule A', however, by exposing Capsule A' with UV radiation in the range of 340-360 nm and limiting the intensity, Capsule A' can be exposed without substantially exposing Capsule B'. Similarly, although the spectral sensitivity of Capsule A' overlaps that of Capsule B', by exposing at 390-400 nm and limiting intensity, Capsule B' can be exposed without substantially exposing Capsule A' or C'. The exposure of Capsule C' can be carried out with much more latitude since at longer wavelengths its spectral sensitivity curve does not substantially overlap the others. Accordingly, microcapsules useful in forming full color images can be obtained by individually incorporating cyan, magenta and yellow color formers in the microcapsules of Fig. 2.
0020The present invention is useful in tailoring the sensitivities of microcapsules throughout the electromagnetic spectrum, but it is particularly useful in narrowing the sensitivity of microcapsules to ultraviolet radiation.
0021The function of the absorber in tailoring the sensitivity of microcapsules is illustrated in Fig. 3 wherein the spectral sensitivity curve (Curve B-1) corresponds to Curve B' in Fig. 2 and is shown in comparison to the spectral sensitivity curve for the same microcapsule without the ultraviolet absorber present (Curve B-2). The photosensitive composition encapsulated in these microcapsules contains 2-isopropylthioxanthone and ethyl-4-dimethvlaminobenzoate as initiators. As can be seen from Curve B-2, this photoinitiator system is quite sensitive at 350 nm as well as at 390 nm. The present invention addresses the problem of decreasing the sensitivity of the system at 350 nm where photosensitivity is not desired.
0022It can be seen from a comparison of Curves B-1 and B-2 that the UV absorber reduces the sensitivity of the microcapsules in the range of 340-360 nm. In this manner, the absorber provides greater latitude in the exposure that may be used to expose Capsule A' in Fig. 2. As Curve B-1 demonstrates, without the UV absorber, Capsule B' would be much more sensitive in the range of 340-360 nm, making it more difficult to select an exposure wavelength for Capsule A' and limit the intensity so as to expose Capsule A' without exposing Capsule B'.
0023The effect of the absorber is further illustrated in Fig. 4 for Capsule C' where Curve C-1 is the spectral sensitivity Curve in Fig. 2 and Curve C-2 is the sensitivity curve for the same microcapsule without the UV absorber. The initiator used in these microcapsules, 7-diethylamino-3-cinnamoylcoumarin (U.S. Patent 4,147,552) and ethyl-4-dimethylaminobenzoate, is highly sensitive at 470 nm and also imparts significant sensitivity at shorter wavelengths. By narrowing the sensitivity of Capsule C', Capsule B' can be exposed at higher wavelengths with less likelihood of exposing Capsule A'.
0024Hereinbelow, the considerations which govern the selection of the absorber are summarized.
0025An absorber should be selected which reduces the sensitivity of the microcapsule in those portions of its spectral sensitivity range which interfere with the exposure of microcapsules at other wavelengths (its inactive range) without overly reducing the sensitivity of the microcapsule in those portions of the spectral sensitivity range in which the microcapsule is intended to be exposed (its active range). In some cases it may be necessary to balance the absorption characteristics of the absorber in the active range and the inactive range to achieve optimum exposure characteristics. Generally absorbers having an extinction coefficient greater than about 100/M cm in the inactive range and less than about 100,000/M cm in the active range of the microcapsule are preferred. When the absorber is directly incorporated into the photosensitive composition, ideally, it should not inhibit free radical polymerization, and it should not generate free radicals upon exposure.
0026The absorbers used in the present capsules can be selected from among those absorbers which are known in the photographic art. Examples of such compounds include dyes conventionally used as silver halide sensitizing dyes in color photography (e.g., cyanine, merocyanine, hemicyanine and.styryl dyes) and ultrayiolet absorbers. A number of colored dyes which absorb outside the desired sensitivity ran<sup>q</sup>e of the microcapsules and do not absorb heavily within the range could also be used as absorbers in the present capsules . Among these, Sudan I, Sudan II, Sudan III, Sudan Orange G, Oil Red O, Oil Blue N, and Fast Garnet GBC are examples of potentially useful compounds.
0027Ultraviolet absorbers that are useful in the present capsules may be selected from hydroxybenzophenones, hydraxyuhenylbenzo-triazoles and formamidines. The absorbers may be used alone or in combination to achieve the spectral sensitivity characteristics that are desired.
0028Representative examples of useful hydroxybenzophenones are 2-hydroxy-4-n-octoxybenzophenone (UV-CHEK AM-300 from Ferro Chemical Division, Mark 1413 from Argus Chemical Division, Witco Chem. Corp., and Cyasorb UV-531 Light Absorber from American Cyanamid), 4-dodecyl-2-hydroxybenzophenone (Eastman Inhibitor DOBP from Eastman Kodak), 2-hydroxy-4-methoxybenzophenone (Cyasorb UV-9 Light Absorber from American Cyanamid), and 2,2'-dihydroxy-4-methoxybenzophenone (Cyasorb UV-24 Light Absorber from American Cyanamid). Representative examples of useful hydroxybenzophenyl benzotriazoles are 2-(2'-hydroxy-5'-methylphenyl) benzotriazole (Tinuvin P from Ciba-Geigy Additives Dept.), 2-(3',5'-ditert-butyl-2' hydroxyphenyl)-5-chlorobenzotriazole (Tinuvin 327 from Ciba-Geigy), and 2-(2-hydroxy-5-t-octylphenyl) benzotriazole (Cyasorb UV-5411 Light Absorber from American Cyanamid). Representative examples of useful formamidines are described in U.S. 4,021,471 and include N-(p-ethoxy-carbonylphenyl)-N'-ethyl-N'-phenylformamidine (Givsorb UV-2 from Givaudan Corp.). The optimum absorber and concentration of absorber for a particular application depends on both the absorption maximum and extinction coefficient of the absorber candidates and the spectral sensitivity characteristics of the associated photoinitiators.
0029With the exception of the incorporation of eg. an ultraviolet absorber, the microcapsules, photosensitive compositions, image-forming agents, developers, and development techniques described in.U.S. Patents 4,399,209 and 4,440,846 can be used in the present invention.
0030The mechanism by which images are formed.using encapsulated photosensitive compositions is described in U.S. Patents 4,399,209 and 4,440,846. Summarizing, exposure produces an increase in the viscosity of the internal phase in the microcapsules which controls the amount of color former which is released from the capsules and is reacted with the developer. This increase in viscosity prevents a fully exposed capsule from rupturing and releasing the internal phase. The imaging mechanism is unclear in that the fully exposed capsule either does not rupture or it ruptures but does not release the internal phase. In the unexposed and underexposed areas, the capsules rupture and release the internal phase and the amount of the internal phase released is a function of the degree of exposure. Tonal characteristics can be achieved when desired. Again, the imaging mechanism is not clear. All the capsules may rupture or because the size of the capsules varies the number of capsules which rupture may be a function of the degree of exposure.
0031In addition to pressure, the capsules can be ruptured by other means including by peeling development, thermal development, solvent vapor, ultrasonic energy or the like. A gas generating agent can be incorporated in the capsules so that they can be ruptured by heating.
0032Known photohardenable compositions can be used in the present capsules . The compositions which are most useful are those which are curable by free radical initiated, addition polymerization or crosslinking. The most common examples of such compositions are compositions which contain an ethylenically unsaturated compound, e.g., a compound containing terminal or pendant vinyl or allylic groups. Such compounds are well known in the art and include acrylic and methacrylic esters of polyhydric alcohols such as trimethylolpropane, pentaerythritol, and the like. Representative-examples include ethylene glycol diacrylate, ethylene glycol dimethacrylate, trimethylolpropane triacrylate (TMPTA), pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, hexanediol-l,6-dimethacrylate, and diethyleneglycol dimethacrylate.
0033Photoinitiators are selected based on their spectral sensitivities such that there is minimum overlap in their spectral sensitivities and the microcapsules have adequate sensitivity in their respective active ranges. As a general rule, the photosensitive composition containing the photoinitiator should provide a microcapsule having a sensitivity (E) less than 10,000 ergs/cm<sup>2</sup> in the desired exposure range. The term "sensitivity" corresponds to the amount of incident radiation required to produce a first loss in density of 0.10 density units. The photosensitive microcapsules of the present invention are by nature positive working. Consequently, when unexposed the microcapsules rupture and activate the color former which reacts with the developer to produce a maximum image density. Thus, the term "sensitivity" represents the minimum exposure necessary to effect a substantive reduction (0.10 density units) in that maximum density.
0034Useful initiators include photoinitiators which generate free radicals upon photochemical cleavage (homolytic initiators) such as certain benzoin ethers and initiators which function via hydrogen abstraction. Preferred initiators are soluble in the radiation sensitive composition. Xanthones, thioxanthones, polycyclic quinones, acetophenones, 3-substituted coumarins, diaryl ketones, diaryl diketones, and benzoin alkyl ethers are particularly useful. Specific examples of useful initiators are benzophenone, Michler's ketone, benzoin methyl ether, 2,2-dimethoxy-2-phenylacetophenone, isopropylthioxanthone, ethyl para-dimethylaminobenzoate, 3-cinnamoyl-7-diethylamino coumarins, etc.
0035To provide a color system which is visible light-sensitive, a potentially useful red initiator is N,N,N',N'- tetra-n-butylthionine; a potentially useful green initiator is N,N,N',N'-tetramethyl-4'-dodecylsafranine, and a potential blue initiator is phenanthraquinone. Another initiator system useful in a red or green light-sensitive microcapsule is described in U.S. Patent No. 3,495,987.
0036The photoinitiator is present in the photosensitive composition in an amount sufficient to initiate polymerization or crosslinking within a suitable exposure time. For example, benzoin methyl ether is typically present in an amount up to about 10% by weight based on the weight of the photocrosslinkable or photopolymerizable species. The exact amount of photoinitiator used will vary with the nature of the photosensitive composition.
0037In accordance with one embodiment of the.present invention, the radiation sensitive composition may additionally include a polythiol to increase the film speed of the microcapsules.
0038Useful polythiols include ethylene glycol bis (thioglycolate) , ethylene glycol bis (β-mercaptopropionate), trimethylolpropane tris (thioglycolate), pentaerythritol tetrakis (thioglycolate) and the most preferred pentaerythritol tetrakis (β-mercaptopropionate) and trimethylolpropane tris (β-mercaptopropionate) , and mixtures thereof. These compounds are commercially available. Certain polymeric polythiols such as polypropylene ether glycol bis (β-mercaptopropionate) which is prepared by esterification of polypropylene ether glycol may also be useful.
0039Various oligomers or polymers can also be used in the present arrangement to improve the film speed of the microcapsules. These materials increase the rate with which the viscosity of the internal phase of the microcapsules builds to a level at which differential release of the internal phase is achieved. These materials must be soluble in the photosensitive composition and not interfere with the photopolymerization reaction. Reactive oligomers contain terminal or pendant ethylenic unsaturation and include urethane, ester and epoxy based reactive acrylate, methacrylate, vinyl and allyl prepolymers. Useful.non-reactive oligomers or polymers are solid or viscous liquids at room temperature but soluble in the unreacted photosensitive composition. Representative examples of some commercially available oligomers or polymers which are useful in the present system include reactive materials such as-diallyl o-phthalate prepolymer (Polysciences), U Vithane 893 (Morton Thiokol, Inc.), Ebercryl 270 (Virginia Chemicals) and non-reactive materials, such as ethyl cellulose, or Lucite.
0040The color former may be associated with the microcapsules in various ways such that upon rupturing the microcapsule and releasing of the internal phase, the color former is able to react and/or migrate to the developer and produce an image. For example, the color former may be encapsulated with the photosensitive composition or incorporated in the wall of a microcapsule having a discrete wall. In the latter case, the photosensitive composition released from the capsules dissolves the color former and transports it to the developer.
0041One example of a useful color former in practise of the invention is a colorless electron donating compound. Representative examples of such color formers include substantially colorless compounds having in their partial skeleton a lactone, a lactam, a sultone, a spiropyran, an ester or an amido structure such as triarylmethane compounds, bisphenylmethane compounds, xanthene compounds, fluorans, thiazine compounds, spiropyran compounds and the like.
0042Cyan, magenta and yellow color precursors useful in practise of the invention can be selected from commercially available materials. Reakt Yellow (186) (a product of BASF), Copikem XI and Copikem XIV (products of Hilton-Davis Chemical Co.) are useful yellow color formers; Cyan S-29663 (an experimental compound from Hilton Davis), Copikem X (a product of Hilton-Davis) and color formers described in U.S. Patent No. 4,322,352 are useful cyan color formers and Copikem XX (a product of Hilton Davis) and Pergascript Red (Ciba-Geigy) are useful as magenta color formers. Other examples of useful color formers are shown below:
0043Yellow color precursors: <chemistry id="chem0001" num="0001"><img file="EP0164931A2_D0001.tif" /></chemistry><chemistry id="chem0002" num="0002"><img file="EP0164931A2_D0002.tif" /></chemistry>
0044Cyan color precursors: <chemistry id="chem0003" num="0003"><img file="EP0164931A2_D0003.tif" /></chemistry><chemistry id="chem0004" num="0004"><img file="EP0164931A2_D0004.tif" /></chemistry><chemistry id="chem0005" num="0005"><img file="EP0164931A2_D0005.tif" /></chemistry><chemistry id="chem0006" num="0006"><img file="EP0164931A2_D0006.tif" /></chemistry>
0045Magenta color precursors: <chemistry id="chem0007" num="0007"><img file="EP0164931A2_D0007.tif" /></chemistry><chemistry id="chem0008" num="0008"><img file="EP0164931A2_D0008.tif" /></chemistry><chemistry id="chem0009" num="0009"><img file="EP0164931A2_D0009.tif" /></chemistry>
0046The color former is incorporated in the internal phase in an amount sufficient to produce a visible image of the desired density upon reaction with a developer or upon transfer. In general, the image former is present in an amount of approximately 0.5 to 20% by weight based on the weight of the internal phase. A preferred range is about 2 to 10% by weight. Transfer imaging materials usually contain about 6% by weight of the color former whereas self-contained materials contain about 1.5 to 3% by weight of the image-forming agent. The relative amounts of the cyan, magenta and yellow color formers in the microcapsules are adjusted to provide satisfactory color balance. In conjunction with this, the relative amounts of the microcapsules in the coating composition can be adjusted to improve color balance.
0047In addition to the photosensitive composition, the internal phase may additionally include a diluent oil. Inclusion of the oil often improves half tone gradation in visual images. Preferred diluent oils are weakly polar solvents having boiling points above 170°C and preferably in the range of 180 to 300°C. Examples of carrier oils are alkylated biphenyls (e.g., monoisopropylbiphenyl), polychlorinated biphenyls, castor oil, mineral oil, deodorized kerosene, naphthenic mineral oils, dibutyl phthalate, dibutyl fumerate, brominated paraffin and mixtures thereof. Alkylated biphenyls and kerosene are generally less toxic and preferred. The amount of diluent oil incorporated in the microcapsules will depend upon the photographic characteristics that are desired in the photosensitive materials. Typically, the diluent oil is used in an amount of approximately 10 to 20% by weight based on the weight of the internal phase:
0048The photosensitive microcapsules can be formed using known encapsulation techniques. The photosensitive composition and associated agents can be encapsulated in hydrophilic wall-forming materials such as gelatin-type materials (see U.S. Patent Nos. 2,730,456 and 2,800, 457 to Green et al) including gum arabic, polyvinyl alcohol, carboxy-methyl-cellulose; resorcinol-formaldehyde wall formers (see U.S. Patent No. 3,755,190 to Hart et al); isocyanate wall-formers (see U.S. Patent No. 3,914,511 to Vassiliades); isocyanate-polyol wall-formers (see U.S. Patent No. 3,796,669 to Kirintani et al); urea formaldehyde wall-formers, particularly urea-resorcinol-. formaldehyde in which oleophilicity is enhanced by the addition of resorcinol (see U.S. Patent Nos. 4,001,140; 4,087,376 and 4,089,802 to Foris et al); and melamine- formaldehyde resin and hydroxypropyl cellulose (see commonly assigned U.S. Patent No. 4,025,455 to Shackle). Urea-formaldehyde microcapsules are preferred for use in practise of the invention . Methods for producing urea formaldehyde capsules which are particularly useful are described in U.S. Patents 4,251,386 and 4,138,362.
0049The mean size of the microcapsules of the present invention suitably ranges from approximately 1 to 25 microns. As a general rule, image resolution improves as capsule size decreases except that if the capsule size is too small, the capsules may disappear in the pore or fiber structure of sqme substrates.
0050The microcapsules of the present invention can be used to form either transfer or self-contained imaging systems, i.e., systems in which the developer is on the same or a separate support from the microcapsules. A detailed description of transfer materials can be found in U.S. Patent No. 4,399,209. Self contained systems are the subject of commonly assigned U.S. Patent 4,440,846.
0051Illustrative examples of color developers useful with the electron donating type color precursors are clay minerals such as acid clay, active clay, attapulgite, etc.; organic acids such as tannic acid, gallic acid, propyl gallate, etc.; acid polymers such as phenol-formaldehyde resins, phenol acetylene condensation resins, condensates between an organic carboxylic acid having at least one hydroxy group and formaldehyde, etc.; metal salts or aromatic carboxylic acids such as zinc salicylate, tin salicylate, zinc 2-hydroxy naphthoate, zinc 3,5 di-tert-butyl salicylate, zinc 3-cyclohexyl-5-( a,a -dimethylbenzyl) salicylate (see U.S. Patents 3,864,146 and 3,934,070), oil soluble metal salts or phenol-formaldehyde novolak resins (e.g., see U.S. Patent Nos. 3,672,935; 3,732,120 and 3,737,410) such as zinc modified oil soluble phenol-formaldehyde resin as disclosed in U.S. Patent No. 3,732,120, zinc carbonate etc. and mixtures thereof.
0052The most common substrate for the photosensitive material of this invention is paper. The paper may be a commercial impact raw stock, or a special grade paper such as cast-coated paper or chrome-rolled paper. Transparent substrates such as polyethylene terephthalate and translucent substrates can also be used in this invention.
0053Photosensitive materials are typically prepared by forming a slurry of the photosensitive microcapsules and coating this slurry on the surface of the appropriate substrate using conventional coating techniques. The coating compositions may additionally contain additives to improve the handling characteristics of the material. Typical examples of such additives are a stilt material such as starch particles and silica particles which prevent specking when the photosensitive material is passed through the nip between two pressure rollers.
0054In coating the microcapsules on the support, it is generally desirable to pre-mix the cyan, magenta and vellow forming capsules rather than to use sequential coating techniques. If the capsules are sequentially coated, a coating sequence should be adopted that assures that the absorber in one capsule does not shield the photosensitive composition in another capsule. The reason for this is that absorbers are selected such that they are active (in terms of absorptivity) in the wavelength regions in which other microcapsules are designed to be sensitive. Hence, unless this precaution is taken using sequential coating, one group of capsules could detrimentally shield another,group of capsules from exposure.
0055Where the microcapsules are respectively sensitive to red, qreen and blue light, the exposure apparatus requires only a light source, means of focusing the light source from the original onto the imaging sheet, means to join the imaging sheet with the developer sheet (in the case of a transfer material), and means for rupturing the microcapsules. Simplified means such as this can be used because development is essentially a dry process with the internal phase and the developer interacting in only infinitesimal droplets.
0056When the microcapsules are not sensitive to visible light, it is necessary to include means for separating the red, green and blue components of the original and translating them into three distinct bands of actinic radiation. Any of the conventional means for electronically processing a visible image may be used for this purpose including a Dunn camera or a matrix camera. Generally, conventional means for accomplishing image translation include color filters to resolve the original into its component images, photoreceptors for sensing the respective component images, means for scanning those photoreceptors and generating an electrical output, and imaging tubes for converting.the output to an appropriate radiation wavelength. In accordance with one exposure device, red, green and blue signals are separated in a color terminal and sent to a Dunn camera. Black and white signals are then sequentially generated on the Dunn CRT screen corresponding to the color signals. Three separate exposures are used through three filters each of which provides a distinct band of actinic radaion to which the cyan, magenta and yellow producing microcapsules are respectively sensitive. Alternatively, an exposure device could be constructed which includes three CRT tubes, each of which has a different output wavelength.
0057The present invention is illustrated in more detail by the following non-limiting Examples wherein the following procedures were used to prepare the microcapsules and the developer sheet.
Capsule Preparation
0058<ul id="ul0002" list-style="none"><li>1. Into a 1200 ml stainless steel beaker, 416 g water and 99.2 g isobutylene maleic anhydride copolymer (18%) are weighed.</li><li>2. The beaker is clamped in place on a hot plate under an overhead mixer. A six-bladed, 45° pitch, turbine impeller is used on the mixer.</li><li>3. After thoroughly mixing, 12.4 g pectin (<sup>p</sup>olygalacturonic acid methyl ester) is slowly sifted into the beaker. This mixture is stirred for 20 minutes.</li><li>4. The pH is adjusted to 4.0 using a 20% solution of H<sub>2</sub>SO<sub>4</sub>, and 0.4 g, Quadrol (2-hydroxypropyl ethylenediamine with propylene oxide from BASF) is added.</li><li>5. The mixer is turned up to 3000 rpm.and the internal phase is added over a period of 10-15 seconds.</li></ul>
0059Emulsification is continued for 10 minutes.
0060<ul id="ul0003" list-style="none"><li>6. At the start of emulsification, the hot plate is turned up so heating continues during emulsification.</li><li>7. After 10 minutes, the mixing speed is reduced to 2000 rpm and 66.4 g urea solution (50% w/w), 3.2 g resorcinol in 20 g water, 85.6 g formaldehyde (37%), and 2.4 g ammonium sulfate in 40 ml water are added at two-minute intervals.</li><li>8. The beaker is covered with foil and a heat gun is used to help bring the temperature of the preparation to 65°C. When 65°C is reached, the hot plate is adjusted to maintain this temperature for a two to three hour cure time during which the capsule walls are formed.</li><li>9. After curing, the heat is turned off and the pH is adjusted to 9.0 using a 20% NaOH solution.</li><li>1<sub>0</sub>. Dry sodium bisulfite (11.2 g) is'added an4 the capsule preparation is cooled to room temperature.</li></ul>
Developer Sheet Preparation
0061A mixture of 852 g water, 250 g 25% Tamol 731 (Rohm & Haas Chemical Co.), 75 g HT clay, 1000 g KC-11 (a synthetic developer manufactured by Fuji Photo Film Company, Ltd.), 15 g Calgon T (Calgon, Inc.) 30 g Dequest 2006 (Monsanto Co.) was ground to a particle size less than 5 microns. To this mixture was added 25 parts HT clay and 10 parts Dow 501 latex per 65 parts of the mixture. The resultant material was coated with a #10 Meyer bar on 80 lb Black and<sup>-</sup>White Enamel base stock at 30 to 35% solids.
Example 1
0062An initiator useful in imparting blue-light sensitivity to capsules is 7-diethylamino-3- cinnamoylcoumarin (U.S. 4,147,552, Specht and Farid). Although highly sensitive at 470 nm, this compound also imparts a significant sensitivity to the capsules at shorter wavelengths. This shorter wavelength sensitivity is a problem which can be dealt with by the inclusion of a UV absorber.
0063A series of capsule batches with different absorbers was produced (as described above) which contained the following internal phase: <tables id="tabl0001" num="0001"><img file="EP0164931A2_D0010.tif" /></tables>
0064Each of the resultant capsule emulsions was diluted 1:1 by weight with water containing 0.5% Triton X-100 surfactant (Rohm and Haas) and coated onto 80 1b. Black and White glossy paper (Mead Corp.) with a No. 12 wire-wound rod. After drying, capsule sheets were exposed with a Kratos 1000W monochrometer system at 350, 390, and 470 nm (20 nm bandpass) through a <maths id="math0001" num=""><img file="EP0164931A2_D0011.tif" /></maths>step wedge (VWR). The geometry of the'system and exposure times were such that the exposure was 10,000 ergs/cm<sup>2</sup> at 350 nm, 13,000 ergs/cm<sup>2</sup> at 390 nm, and 23,500 ergs/cm<sup>2</sup> at 470 nm. Every two steps down the step tablet resulted in a decrease in exposure by a factor of two. Thus, the larger the number in the below table, the less energy is required for a given response. <tables id="tabl0002" num="0002"><img file="EP0164931A2_D0012.tif" /></tables>
0065As can be seen from the data, addition of the absorber decreases the photographic speed at 350 nm in each case and at 390 nm in most cases. Differences in speed among absorbers are due to differences in molecular weight, extinction coefficient, and the shape of the absorption curve.
Example 2
0066Capsules (B-1) were produced as outlined above which contained the following internal phase: <tables id="tabl0003" num="0003"><img file="EP0164931A2_D0013.tif" /></tables>
0067A second capsule batch (B-2) was produced as above, but no Givsorb UV-2 was added. Both capsule batches were coated as in Example 1. With the exposure device described in Example 1, a series of stepwedge (64 sec.) exposures (20 nm bandpass) were made at 10 nm intervals to give the spectral sensitivity curves shown in Fig. 3. As can be seen by an examination of Fig. 3, the spectral sensitivity curve for ITX is appreciably sharpened by addition of the UV absorber. This allows the use of an initiator which absorbs maximally at 350 nm in the three-color system. At 350 nm, the capsule batch containing the absorber requires about 2.83 (three steps) times more light than the capsule batch without absorber to effect the same photographic response.
Example 3
0068Capsules (C-1) were produced as outlined above which contained the following internal phase: <tables id="tabl0004" num="0004"><img file="EP0164931A2_D0014.tif" /></tables>
0069A second capsule batch (C-2) was produced as above, but no Tinuvin 326 was added. Both capsules types were coated as in Example 1. A series of stepwedge exposures (20 nm bandwidth, 64 seconds) was made at 10 nm intervals to obtain the spectral sensitivity curves shown in Fig. 4.
0070As can be seen, addition of the absorber lowered the sensitivity of the system at shorter wavelengths, thus decreasing the spectral overlap in the three-color system shown in Fig. 2. At 390 nm, for example, the system is slowed by two stops (a factor of four) by addition of the UV absorber.
Example 4
0071A photopolymerizable, microencapsulated, full-color, imaging system involving three types of microcapsules each containing a different dye precursor and sensitive at one of three wavelengths was prepared. Capsules A' are sensitive at 350 nm and contain a magenta precursor; Capsules B' are sensitive at 390 nm and contain a cyan precursor; and Capsules C' are sensitive at 470 nm and contain a yellow precursor.
0072Capsules A', B', and C' were prepared using the above procedure and the following internal phases. The internal phases were prepared by adding the monomer, photoinitiator, and color former to a 400 ml beaker, heating to 140°C and stirring until all three had dissolved. Thereafter the isocyanate was added and emulsified.
Internal Phases
0073<tables id="tabl0005" num="0005"><img file="EP0164931A2_D0015.tif" /></tables><tables id="tabl0006" num="0006"><img file="EP0164931A2_D0016.tif" /></tables><tables id="tabl0007" num="0007"><img file="EP0164931A2_D0017.tif" /></tables>
0074Capsules A', B' and C' are mixed such that the combination of the three gives a neutral black when developed. The formulation used for coating is 113 g Capsule A', 150 g Capsule B' and 118 g Capsule C', 225 g 1% Triton X-100, 20 drops Triton X-100 and 120 g 5% Klucel L. The capsules and the Triton X-100 with water are mixed together and put in an ultrasonic bath for approximately 10 minutes to facilitate good mixing and break up any agglomerates that may have formed. The mixture is then filtered through 3-6 layers of cheesecloth. Finally, the Klucel L is stirred into the mixture and it is ready for coating.
0075The coating machine used is a Talboys Model ≠ 1217 coater. The above described formulation is coated on this machine using a ≠ 12 wire-wound Meyer bar on 8½ inch (21.6 cm) wide 80≠ Black and White Glossy basestock. This gives a capsule coatweight of 4-6 g/m<sup>2</sup>. Light sensitive, full colour, imaging paper is thus produced.
Exposure and Development
0076The paper produced as described above is exposed with a Kratos Monochromatic Illumination System, Model MIS 1000 having a 1000 watt Xenon arc light source fitted with a GM 252 high intensity grating in which the converging lens has been removed.. This modification gives an exposure field large enough to expose 8<sup>m</sup> x 10" (20.3 cm x 25.4 cm) sheets at a distance of about 58 inches (1.37 m) from the monochrometer. Colour separation masks (Accucolor, Dayton, Ohio) are used in which a picture is taken through red, green, and blue filters and each is printed on a transparent base film. The green filter mask thus produced is placed over the. light sensitive paper with proper registration. The monochrometer is set at 350 nm with a 20 nm bandwidth. The capsules are exposed through the mask for 15-30 seconds. The green filter mask is removed and the red filter mask is placed over the imaging sheet and registered. The monochrometer is set at 390 nm with a 20 nm bandwidth. The capsules are exposed for 20-30 seconds. This mask is then removed and replaced with the blue filter mask. Wavelength is set at 470 nm, again with a 20 nm bandwidth, and the capsules are exposed for 10-20 seconds. The exposed sheet is placed face down against a resin developer sheet prepared as set forth above. These two sheets are run together through a calender stack with nip pressure of about 500 pli which breaks the unexposed or underexposed capsules, transfers the oil to the developer sheet, develops the dye, and forms a full calor image. The speed of development can be enhanced by heating the sheet for about 30 seconds at 90°C.
Sensitivity
0077The spectral sensitivities of the capsules are graphed in Fig. 2. These curves were generated by exposing paper coated with one of the three capsule types through a 21 step photographic step table at each 10 nm increment through the wavelength range 300-500 nm on the monochrometer described above with a 20 nm bandwidth. The densities of each stepwedge image produced was read on a Macbeth densitometer and H and D curves were plotted at each wavelength measured with the aid of a computer , program which takes into account the spectral output pf the light source and the exposure time so that the curves plotted are in ergs/cm<sup>2</sup>. The speeds at 90% density and at 10% density are calculated where 100% density or Dmax is unexposed and 0% density or Dmin is fully exposed. <sub>F</sub>ig. 2 plots the speeds at 10% density for capsules A', . B', and C'. Capsule A' has a 350 nm sensitivity of 300 ergs/cm<sup>2</sup> at 90% density and 800 ergs/cm<sup>2</sup>, at 10% density. This capsule is exposed at 350 nm rather than 360 nm because capsule B' is more sensitive at 360 nm than at 350 nm. Capsule B' has a 390 nm sensitivity of 450 ergs/cm<sup>2</sup> at 90% density and 1100 ergs/cm<sup>2</sup> at 20% density. Capsule C' has a 470 nm sensitivity of 550 ergs/cm<sup>2</sup> at 90% density and 2300 ergs/cm<sup>2</sup> at 10% density. The sensitivity of the photosensitive material is between about 800 and 2300 ergs/cm<sup>2</sup>.
Example 5
0078A microencapsulated full color imaging system was prepared and evaluated as in Example 4 except as noted below.
0079Capsules A", B" and C" were prepared by following the encapsulation procedure set forth above using the following internal phase compositions: <tables id="tabl0008" num="0008"><img file="EP0164931A2_D0018.tif" /></tables><tables id="tabl0009" num="0009"><img file="EP0164931A2_D0019.tif" /></tables>
Capsule C"
0080Same as C' in Example 4.
0081The internal phase was prepared by dissolving the monomer, photoinitiator and color former as in Example 4; cooling the solution to room temperature and adding the propylene carbonate having the PIP<sup>+</sup>PF<sup>-</sup><sub>6</sub> dissolved therein; adding the isocyanates, mixing thoroughly for two minutes, and emulsifying.
0082The capsules were mixed to give neutral black . when developed and coated on a support as in Example 4. The spectral sensitivities of the capsules are plotted in Fig. 5. Capsule A" has a 350 nm sensitivity of 200 ergs/cm<sup>2</sup> at 90% density and 500 ergs/cm<sup>2</sup> at 10% density. Capsule B" has a 390 nm sensitivity of 180 ergs/cm<sup>2</sup> at 90% density and 380 ergs/cm<sup>2</sup> at 10% density. Capsule C" has a 470 nm sensitivity of 550 ergs/cm<sup>2</sup> at 90% density and 2300 ergs/cm<sup>2</sup> at 10<sub>%</sub> density. Capsule C" did not include the diphenyliodonium hexafluorophosphate, which would make the system faster. Had the capsules included the PIP<sup>+</sup>PF<sup>-</sup><sub>6</sub>, the speed at 470 nm would haue been increased, but the speeds at 390 nm and 350 nm would also have been increased making color separation difficult. The sensitivity of the system, then, is between 380 and 2300 ergs/cm<sup>2</sup>.
22 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0343915A2 | Cited by | European Patent Office (EPO) | Search report |
| EP0412570A2 | Cited by | European Patent Office (EPO) | Search report |
| US5049920A | Cited by | United States of America | Search report |
| GB2230868B | Cited by | United Kingdom | Search report |
| GB2190759A | Cited by | United Kingdom | Search report |
| EP0263609A3 | Cited by | European Patent Office (EPO) | Search report |
| EP0263609A2 | Cited by | European Patent Office (EPO) | Search report |
| EP0318336A2 | Cited by | European Patent Office (EPO) | Search report |
| EP0308274B1 | Cited by | European Patent Office (EPO) | Examiner |
| GB2201803B | Cited by | United Kingdom | Search report |
| EP0249429A3 | Cited by | European Patent Office (EPO) | Search report |
| GB2190210A | Cited by | United Kingdom | Search report |
| US6579328B2 | Cited by | United States of America | Applicant |
| US4922286A | Cited by | United States of America | Search report |
| GB2190210B | Cited by | United Kingdom | Search report |
| US4943509A | Cited by | United States of America | Search report |
| EP0308274A2 | Cited by | European Patent Office (EPO) | Examiner |
| GB2190759B | Cited by | United Kingdom | Search report |
| US6547841B2 | Cited by | United States of America | Applicant |
| FR2650682A1 | Cited by | France | Search report |
| GB2201803A | Cited by | United Kingdom | Search report |
| GB2206419B | Cited by | United Kingdom | Search report |
| US4893147A | Cited by | United States of America | Search report |
| FR2609190A1 | Cited by | France | Search report |
| EP0412026A1 | Cited by | European Patent Office (EPO) | Search report |
| GB2199416B | Cited by | United Kingdom | Search report |
| EP0343915A3 | Cited by | European Patent Office (EPO) | Search report |
| EP0318336A3 | Cited by | European Patent Office (EPO) | Search report |
| GB2199416A | Cited by | United Kingdom | Search report |
| US5091280A | Cited by | United States of America | Search report |
| EP0412570A3 | Cited by | European Patent Office (EPO) | Search report |
| FR2611390A1 | Cited by | France | Search report |
| GB2230868A | Cited by | United Kingdom | Search report |
| EP0249429A2 | Cited by | European Patent Office (EPO) | Search report |
| GB2206419A | Cited by | United Kingdom | Search report |
| GB2113860A | Cites | United Kingdom | Search report |
| US4362809A | Cites | United States of America | Search report |
12 members in 7 offices; this record represents the family
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 62099484 | United States of America | A | |
| 620994 | United States of America | – | |
| US19840620994 | – | – | – |
| 620994 | – | – | – |
Members12
| Document | Office | Kind | |
|---|---|---|---|
| DK268385D0 | Denmark | D0 | |
| DK268385A | Denmark | A | |
| EP0164931A2This record | European Patent Office (EPO) | A2 | |
| KR860000581A | Republic of Korea | A | |
| JPS6124495A | Japan | A | |
| US4576891A | United States of America | A | |
| EP0164931A3 | European Patent Office (EPO) | A3 | |
| CA1262651A | Canada | A | |
| EP0164931B1 | European Patent Office (EPO) | B1 | |
| DE3579946D1 | Germany | D1 | |
| DK161269B | Denmark | B | |
| KR920005767B1 | Republic of Korea | B1 |
37 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| It: last paid annual feeITTA | ITTA | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0164931
- Publication, DOCDB
- 0164931
- Publication, EPODOC
- EP0164931
- Application
- 85303484
- Application, DOCDB
- 85303484
- Application, EPODOC
- EP19850303484
Titles6
- German
- Lichtempfindliche Materialien und die diese Materialien verwendenden Aufzeichnungsverfahren.
- English
- Photosensitive materials and imaging processes using such materials.
- French
- Matériaux photosensibles et procédés d'enregistrement d'images utilisant de tels matériaux.
- German
- Lichtempfindliche Materialien und die diese Materialien verwendenden Aufzeichnungsverfahren
- English
- Photosensitive materials and imaging processes using such materials
- French
- Matériaux photosensibles et procédés d'enregistrement d'images utilisant de tels matériaux
Classification
- CPC, 5
- G03F7/002
- Y10S430/127
- Y10T428/2984
- Y10T428/2985
- Y10T428/2989
- IPC, 4
- B41M5 165
- B01J13 02
- G03F7 00
- G03F7 004
Designated states7
- Contracting states, 7
- Belgium
- Germany
- France
- United Kingdom
- Italy
- Netherlands (Kingdom of the)
- Sweden